Literature DB >> 6885965

Effects of tyrosine and tryptophan ingestion on plasma catecholamine and 3,4-dihydroxyphenylacetic acid concentrations.

D D Rasmussen, B Ishizuka, M E Quigley, S S Yen.   

Abstract

The effect of oral tyrosine or tryptophan ingestion on plasma concentrations of norepinephrine (NE), dopamine (DA), epinephrine (EPI), and 3,4-dihydroxyphenylacetic acid (DOPAC) was investigated in a double blind, placebo-controlled study in fasted men. Tyrosine ingestion induced within 45 min a significant but short-lasting (approximately 30 min) increase in plasma concentrations of NE, EPI, and DA and a coincident decrease in plasma DOPAC levels. Ingestion of tryptophan or lactose placebo did not after plasma DA, EPI, NE, or DOPAC levels. Since plasma catecholamines derive from peripheral sources, while circulating DOPAC may reflect both brain and peripheral DA turnover, these results suggest that the oral ingestion of tyrosine can exert acute effects on catecholamine systems within and outside the brain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885965     DOI: 10.1210/jcem-57-4-760

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Effect of protein ingestion on urinary dopamine excretion. Evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man.

Authors:  M Williams; J B Young; R M Rosa; S Gunn; F H Epstein; L Landsberg
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

2.  Modulation of the actions of tyrosine by alpha 2-adrenoceptor blockade.

Authors:  S Al-Damluji; G Ross; R Touzel; D Perrett; A White; G M Besser
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

3.  Metabolome-wide association study of anti-epileptic drug treatment during pregnancy.

Authors:  Douglas I Walker; Kayla Perry-Walker; Richard H Finnell; Kurt D Pennell; Vilinh Tran; Ryan C May; Thomas F McElrath; Kimford J Meador; Page B Pennell; Dean P Jones
Journal:  Toxicol Appl Pharmacol       Date:  2018-12-04       Impact factor: 4.219

4.  Compositional epistasis detection using a few prototype disease models.

Authors:  Lu Cheng; Mu Zhu
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

5.  Tyrosine loading in patients with hepatic cirrhosis: lack of effect on plasma catecholamines.

Authors:  H Wernze; K L Diehl; P Hermann; G Peter
Journal:  Klin Wochenschr       Date:  1986-12-01

6.  A role for foregut tyrosine metabolism in glucose tolerance.

Authors:  Judith Korner; Gary W Cline; Mark Slifstein; Pasquale Barba; Gina R Rayat; Gerardo Febres; Rudolph L Leibel; Antonella Maffei; Paul E Harris
Journal:  Mol Metab       Date:  2019-02-27       Impact factor: 7.422

Review 7.  pH-Responsive Polypeptide-Based Smart Nano-Carriers for Theranostic Applications.

Authors:  Rimesh Augustine; Nagendra Kalva; Ho An Kim; Yu Zhang; Il Kim
Journal:  Molecules       Date:  2019-08-15       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.